General Comments / Chat, page-7697

Can't do better on my phone.
Not huge amount of time to scour as I'm busy
Appears on first glance that patent lodgement for cardioprotection properties as a blanket with all anticancer indications was rejected as its not a reasonable assumption that because it can protect from anthracyclines that it will also impart cardioprotection to other agents.

I'm *really* rushing here as I'm real busy and doing two other jobs, so hopefully someone else can look at it better.

I didn't see a suggestion that cardioprotection for anthracylines was rejected (paragraphs I saw re: same, seemed exciting on a glance)

I'll wait for someone with more time hopefully and/or official announcements